欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-CD5 mAbs

简要描述:

This antibody binds human CD5, which is a surface glycoprotein that act as a receptor in regulating T-cell proliferation. CD5 is a good immunohistochemical marker for T-cells.

产品参数:

Cat. No.:MABL-1022

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:therapeutic, FC

详细介绍

Key features and details


Cat. No.

MABL-1022

Name

Anti-CD5 mAbs

Clone No.

AFD- H65

From

Recombinant Antibody

Isotype

Engineer antibody

Application

therapeutic, FC

Species Reactivity

Human

Basic Information


Specificity

This antibody binds human CD5, which is a   surface glycoprotein that act as a receptor in regulating T-cell   proliferation. CD5 is a good immunohistochemical marker for T-cells.

Alternative Name

LEU1; T-cell surface glycoprotein CD5;   Lymphocyte antigen T1/Leu-1; Tp67 antigen

UniProt

P06127

Immunogen

The original antibody was generated by   immunizing a BALB/c mice with human T cell line HSB-2, which was isolated   from a patient with T cell acute lymphocytic leukemia.

Application Notes

This antibody was used for the generation of   a ricin A chain anti-T lymphocyte immunotoxin (H65-RTA) and was examined for   its ability to bind to lymphocytes, to inhibit protein synthesis in a cell   free system, and to inhibit lymphocyte transformation without affecting   hematopoietic progenitor cells as measured by the in vitro colony assays. It  was reported that the immunotoxin was an effective agent against   immunocompetent T lymphocytes in vitro and may be an effective agent for use   in clinical bone marrow transplantation (PMID 6609971). A safety and efficacy study of this lymphocyte-targeted   immunotoxin was conducted in patients with severe acute steroid-resistant   graft-versus-host disease (AGVHD) in a phase I-II dose escalation study with   group expansion at the two middle doses. It was seen that under appropriate   conditions, H65-RTA can produce up to a 98% depletion of T lymphocytes from   human bone marrow without decreasing the number of committed hematopoietic  progenitor cells.

Antibody First Published

Kernan et al. Specific inhibition of in   vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain   immunotoxin. J Immunol. 1984 Jul;133(1)137-46. PMID6609971

Note on publication

Describes the generation of a ricin A toxin   conjugated antibody immunotoxin and evaluates its ability to inhibit in vitro   T lymphocyte transformation.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-CD49F mAbs

下一篇: Anti-CD5 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号